# Nicotinic Agonist Effects on BMI and Neuronal Response

> **NCT02458313** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 61 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** DMXB-A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02458313
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-14
- **Primary completion:** 2021-12-13
- **Final completion:** 2021-12-13
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2023-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458313, "Nicotinic Agonist Effects on BMI and Neuronal Response". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02458313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*